Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

Oncology Learning Network

Ibrutinib Combined with Obinutuzumab and Venetoclax for the Frontline Treatment of Older Patients with CLL

Hematology/Oncology August 14th 2023

ReachMD

Keeping Pace in Hematologic Malignancies: 2023 Contextualizing the Evidence: Newly Diagnosed AML in Difficult-to-Treat Subtypes (CME)

Clinical Pharmacology July 25th 2023

Clinical Advances in Hematology & Oncology

Highlights in Leukemia and Lymphoma

Hematology/Oncology July 25th 2023

Oncology News Central (ONC)

Cross-border ‘Twinning Programs’ May Reduce Survival Disparities for Childhood Leukemia

Hematology/Oncology June 12th 2023

Hematology Advisor

Nutrition-Related Challenges Common for Older Adults with AML, MDS

Geriatrics May 16th 2023

Northwestern Medicine

Four Feinberg Faculty Elected to American Academy of Arts and Sciences

All Specialties May 2nd 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form